Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
Clinical trial NCT00116649 · COMPLETED
Trial details
- NCT number
- NCT00116649
- Sponsor
- Graceway Pharmaceuticals, LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2007-05-01
- Enrollment
- 551
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.